|
|
Article: Apotex Victory in Generic Paxil Confirmed; Federal Circuit Court of Appeals Affirms District Court's Judgment in Favor of Apotex.
- Article from:
- Business Wire
- Article date:
- April 26, 2004
CopyrightCOPYRIGHT 2004 Business Wire. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Business Editors/Health/Medical Writers
WESTON, Fla.--(BUSINESS WIRE)--April 26, 2004
Apotex Corp. today praised the decision of the U.S. Court of Appeals for the Federal Circuit holding that GSK's U.S. Patent No. 4,721,723, the patent covering Paxil(R) (paroxetine hydrochloride), is invalid.
"We feel vindicated with this decision," said Apotex Chief Executive Officer Dr. Barry Sherman. "This confirms what we have been arguing since 1998: our generic version of Paxil(R) does not infringe any valid patents and deserves to be on the market," Dr. Sherman added.
"This is further affirmation," continued Dr. Sherman, "that GSK has kept an ...